On Tuesday, Immuneering Corp (NASDAQ: IMRX) opened lower -4.29% from the last session, before settling in for the closing price of $6.52. Price fluctuations for IMRX have ranged from $1.10 to $10.08 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -46.45% over the last five years. Company’s average yearly earnings per share was noted 30.56% at the time writing. With a float of $47.77 million, this company’s outstanding shares have now reached $63.48 million.
Immuneering Corp (IMRX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Immuneering Corp is 26.02%, while institutional ownership is 41.88%. The most recent insider transaction that took place on Oct 03 ’25, was worth 50,025. In this transaction Director of this company bought 7,500 shares at a rate of $6.67, taking the stock ownership to the 156,766 shares. Before that another transaction happened on Oct 01 ’25, when Company’s Chief Accounting Officer bought 300 for $6.39, making the entire transaction worth $1,917. This insider now owns 27,533 shares in total.
Immuneering Corp (IMRX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.58 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.44) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.55% during the next five years compared to -46.45% drop over the previous five years of trading.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Check out the current performance indicators for Immuneering Corp (IMRX). In the past quarter, the stock posted a quick ratio of 24.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Analysing the last 5-days average volume posted by the [Immuneering Corp, IMRX], we can find that recorded value of 0.68 million was lower than the volume posted last year of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 6.06%.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 46.52%, which indicates a significant increase from 2.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.51, while its 200-day Moving Average is $3.98. Now, the first resistance to watch is $6.48. This is followed by the second major resistance level at $6.72. The third major resistance level sits at $6.86. If the price goes on to break the first support level at $6.10, it is likely to go to the next support level at $5.96. Should the price break the second support level, the third support level stands at $5.72.
Immuneering Corp (NASDAQ: IMRX) Key Stats
There are currently 64,570K shares outstanding in the company with a market cap of 402.92 million. Presently, the company’s annual sales total 0 K according to its annual income of -61,040 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -14,960 K.
